Global AI-assisted Drug Design (AIDD) Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global AI-assisted Drug Design (AIDD) market size was valued at USD 1405.9 million in 2022 and is forecast to a readjusted size of USD 8513.8 million by 2029 with a CAGR of 29.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Artificial intelligence (AI) has the potential to revolutionize the drug discovery process,
offering improved efficiency, accuracy, and speed.
This report is a detailed and comprehensive analysis for global AI-assisted Drug Design (AIDD) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global AI-assisted Drug Design (AIDD) market size and forecasts, in consumption value ($ Million), 2018-2029
Global AI-assisted Drug Design (AIDD) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global AI-assisted Drug Design (AIDD) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global AI-assisted Drug Design (AIDD) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI-assisted Drug Design (AIDD)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI-assisted Drug Design (AIDD) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IBM, Exscientia, Google(Alphabet), Microsoft and Atomwise, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
AI-assisted Drug Design (AIDD) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe AI-assisted Drug Design (AIDD) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI-assisted Drug Design (AIDD), with revenue, gross margin and global market share of AI-assisted Drug Design (AIDD) from 2018 to 2023.
Chapter 3, the AI-assisted Drug Design (AIDD) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and AI-assisted Drug Design (AIDD) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of AI-assisted Drug Design (AIDD).
Chapter 13, to describe AI-assisted Drug Design (AIDD) research findings and conclusion.
Artificial intelligence (AI) has the potential to revolutionize the drug discovery process,
offering improved efficiency, accuracy, and speed.
This report is a detailed and comprehensive analysis for global AI-assisted Drug Design (AIDD) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global AI-assisted Drug Design (AIDD) market size and forecasts, in consumption value ($ Million), 2018-2029
Global AI-assisted Drug Design (AIDD) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global AI-assisted Drug Design (AIDD) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global AI-assisted Drug Design (AIDD) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI-assisted Drug Design (AIDD)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI-assisted Drug Design (AIDD) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IBM, Exscientia, Google(Alphabet), Microsoft and Atomwise, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
AI-assisted Drug Design (AIDD) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Hardware
- Software
- Service
- Early Drug Discovery
- Preclinical Phase
- Clinical Phase
- Regulatory Approval
- IBM
- Exscientia
- Google(Alphabet)
- Microsoft
- Atomwise
- Schrodinger
- Aitia
- Insilico Medicine
- NVIDIA
- XtalPi
- BPGbio
- Owkin
- CytoReason
- Deep Genomics
- Cloud Pharmaceuticals
- BenevolentAI
- Cyclica
- Verge Genomics
- Valo Health
- Envisagenics
- Euretos
- BioAge Labs
- Iktos
- BioSymetrics
- Evaxion Biotech
- Aria Pharmaceuticals
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe AI-assisted Drug Design (AIDD) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI-assisted Drug Design (AIDD), with revenue, gross margin and global market share of AI-assisted Drug Design (AIDD) from 2018 to 2023.
Chapter 3, the AI-assisted Drug Design (AIDD) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and AI-assisted Drug Design (AIDD) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of AI-assisted Drug Design (AIDD).
Chapter 13, to describe AI-assisted Drug Design (AIDD) research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of AI-assisted Drug Design (AIDD)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AI-assisted Drug Design (AIDD) by Type
1.3.1 Overview: Global AI-assisted Drug Design (AIDD) Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global AI-assisted Drug Design (AIDD) Consumption Value Market Share by Type in 2022
1.3.3 Hardware
1.3.4 Software
1.3.5 Service
1.4 Global AI-assisted Drug Design (AIDD) Market by Application
1.4.1 Overview: Global AI-assisted Drug Design (AIDD) Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Early Drug Discovery
1.4.3 Preclinical Phase
1.4.4 Clinical Phase
1.4.5 Regulatory Approval
1.5 Global AI-assisted Drug Design (AIDD) Market Size & Forecast
1.6 Global AI-assisted Drug Design (AIDD) Market Size and Forecast by Region
1.6.1 Global AI-assisted Drug Design (AIDD) Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global AI-assisted Drug Design (AIDD) Market Size by Region, (2018-2029)
1.6.3 North America AI-assisted Drug Design (AIDD) Market Size and Prospect (2018-2029)
1.6.4 Europe AI-assisted Drug Design (AIDD) Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific AI-assisted Drug Design (AIDD) Market Size and Prospect (2018-2029)
1.6.6 South America AI-assisted Drug Design (AIDD) Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa AI-assisted Drug Design (AIDD) Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 IBM
2.1.1 IBM Details
2.1.2 IBM Major Business
2.1.3 IBM AI-assisted Drug Design (AIDD) Product and Solutions
2.1.4 IBM AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 IBM Recent Developments and Future Plans
2.2 Exscientia
2.2.1 Exscientia Details
2.2.2 Exscientia Major Business
2.2.3 Exscientia AI-assisted Drug Design (AIDD) Product and Solutions
2.2.4 Exscientia AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Exscientia Recent Developments and Future Plans
2.3 Google(Alphabet)
2.3.1 Google(Alphabet) Details
2.3.2 Google(Alphabet) Major Business
2.3.3 Google(Alphabet) AI-assisted Drug Design (AIDD) Product and Solutions
2.3.4 Google(Alphabet) AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Google(Alphabet) Recent Developments and Future Plans
2.4 Microsoft
2.4.1 Microsoft Details
2.4.2 Microsoft Major Business
2.4.3 Microsoft AI-assisted Drug Design (AIDD) Product and Solutions
2.4.4 Microsoft AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Microsoft Recent Developments and Future Plans
2.5 Atomwise
2.5.1 Atomwise Details
2.5.2 Atomwise Major Business
2.5.3 Atomwise AI-assisted Drug Design (AIDD) Product and Solutions
2.5.4 Atomwise AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Atomwise Recent Developments and Future Plans
2.6 Schrodinger
2.6.1 Schrodinger Details
2.6.2 Schrodinger Major Business
2.6.3 Schrodinger AI-assisted Drug Design (AIDD) Product and Solutions
2.6.4 Schrodinger AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Schrodinger Recent Developments and Future Plans
2.7 Aitia
2.7.1 Aitia Details
2.7.2 Aitia Major Business
2.7.3 Aitia AI-assisted Drug Design (AIDD) Product and Solutions
2.7.4 Aitia AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Aitia Recent Developments and Future Plans
2.8 Insilico Medicine
2.8.1 Insilico Medicine Details
2.8.2 Insilico Medicine Major Business
2.8.3 Insilico Medicine AI-assisted Drug Design (AIDD) Product and Solutions
2.8.4 Insilico Medicine AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Insilico Medicine Recent Developments and Future Plans
2.9 NVIDIA
2.9.1 NVIDIA Details
2.9.2 NVIDIA Major Business
2.9.3 NVIDIA AI-assisted Drug Design (AIDD) Product and Solutions
2.9.4 NVIDIA AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 NVIDIA Recent Developments and Future Plans
2.10 XtalPi
2.10.1 XtalPi Details
2.10.2 XtalPi Major Business
2.10.3 XtalPi AI-assisted Drug Design (AIDD) Product and Solutions
2.10.4 XtalPi AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 XtalPi Recent Developments and Future Plans
2.11 BPGbio
2.11.1 BPGbio Details
2.11.2 BPGbio Major Business
2.11.3 BPGbio AI-assisted Drug Design (AIDD) Product and Solutions
2.11.4 BPGbio AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 BPGbio Recent Developments and Future Plans
2.12 Owkin
2.12.1 Owkin Details
2.12.2 Owkin Major Business
2.12.3 Owkin AI-assisted Drug Design (AIDD) Product and Solutions
2.12.4 Owkin AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Owkin Recent Developments and Future Plans
2.13 CytoReason
2.13.1 CytoReason Details
2.13.2 CytoReason Major Business
2.13.3 CytoReason AI-assisted Drug Design (AIDD) Product and Solutions
2.13.4 CytoReason AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 CytoReason Recent Developments and Future Plans
2.14 Deep Genomics
2.14.1 Deep Genomics Details
2.14.2 Deep Genomics Major Business
2.14.3 Deep Genomics AI-assisted Drug Design (AIDD) Product and Solutions
2.14.4 Deep Genomics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Deep Genomics Recent Developments and Future Plans
2.15 Cloud Pharmaceuticals
2.15.1 Cloud Pharmaceuticals Details
2.15.2 Cloud Pharmaceuticals Major Business
2.15.3 Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Product and Solutions
2.15.4 Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Cloud Pharmaceuticals Recent Developments and Future Plans
2.16 BenevolentAI
2.16.1 BenevolentAI Details
2.16.2 BenevolentAI Major Business
2.16.3 BenevolentAI AI-assisted Drug Design (AIDD) Product and Solutions
2.16.4 BenevolentAI AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 BenevolentAI Recent Developments and Future Plans
2.17 Cyclica
2.17.1 Cyclica Details
2.17.2 Cyclica Major Business
2.17.3 Cyclica AI-assisted Drug Design (AIDD) Product and Solutions
2.17.4 Cyclica AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Cyclica Recent Developments and Future Plans
2.18 Verge Genomics
2.18.1 Verge Genomics Details
2.18.2 Verge Genomics Major Business
2.18.3 Verge Genomics AI-assisted Drug Design (AIDD) Product and Solutions
2.18.4 Verge Genomics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Verge Genomics Recent Developments and Future Plans
2.19 Valo Health
2.19.1 Valo Health Details
2.19.2 Valo Health Major Business
2.19.3 Valo Health AI-assisted Drug Design (AIDD) Product and Solutions
2.19.4 Valo Health AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Valo Health Recent Developments and Future Plans
2.20 Envisagenics
2.20.1 Envisagenics Details
2.20.2 Envisagenics Major Business
2.20.3 Envisagenics AI-assisted Drug Design (AIDD) Product and Solutions
2.20.4 Envisagenics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Envisagenics Recent Developments and Future Plans
2.21 Euretos
2.21.1 Euretos Details
2.21.2 Euretos Major Business
2.21.3 Euretos AI-assisted Drug Design (AIDD) Product and Solutions
2.21.4 Euretos AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Euretos Recent Developments and Future Plans
2.22 BioAge Labs
2.22.1 BioAge Labs Details
2.22.2 BioAge Labs Major Business
2.22.3 BioAge Labs AI-assisted Drug Design (AIDD) Product and Solutions
2.22.4 BioAge Labs AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 BioAge Labs Recent Developments and Future Plans
2.23 Iktos
2.23.1 Iktos Details
2.23.2 Iktos Major Business
2.23.3 Iktos AI-assisted Drug Design (AIDD) Product and Solutions
2.23.4 Iktos AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Iktos Recent Developments and Future Plans
2.24 BioSymetrics
2.24.1 BioSymetrics Details
2.24.2 BioSymetrics Major Business
2.24.3 BioSymetrics AI-assisted Drug Design (AIDD) Product and Solutions
2.24.4 BioSymetrics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 BioSymetrics Recent Developments and Future Plans
2.25 Evaxion Biotech
2.25.1 Evaxion Biotech Details
2.25.2 Evaxion Biotech Major Business
2.25.3 Evaxion Biotech AI-assisted Drug Design (AIDD) Product and Solutions
2.25.4 Evaxion Biotech AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.25.5 Evaxion Biotech Recent Developments and Future Plans
2.26 Aria Pharmaceuticals
2.26.1 Aria Pharmaceuticals Details
2.26.2 Aria Pharmaceuticals Major Business
2.26.3 Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Product and Solutions
2.26.4 Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.26.5 Aria Pharmaceuticals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AI-assisted Drug Design (AIDD) Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of AI-assisted Drug Design (AIDD) by Company Revenue
3.2.2 Top 3 AI-assisted Drug Design (AIDD) Players Market Share in 2022
3.2.3 Top 6 AI-assisted Drug Design (AIDD) Players Market Share in 2022
3.3 AI-assisted Drug Design (AIDD) Market: Overall Company Footprint Analysis
3.3.1 AI-assisted Drug Design (AIDD) Market: Region Footprint
3.3.2 AI-assisted Drug Design (AIDD) Market: Company Product Type Footprint
3.3.3 AI-assisted Drug Design (AIDD) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AI-assisted Drug Design (AIDD) Consumption Value and Market Share by Type (2018-2023)
4.2 Global AI-assisted Drug Design (AIDD) Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AI-assisted Drug Design (AIDD) Consumption Value Market Share by Application (2018-2023)
5.2 Global AI-assisted Drug Design (AIDD) Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America AI-assisted Drug Design (AIDD) Consumption Value by Type (2018-2029)
6.2 North America AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2029)
6.3 North America AI-assisted Drug Design (AIDD) Market Size by Country
6.3.1 North America AI-assisted Drug Design (AIDD) Consumption Value by Country (2018-2029)
6.3.2 United States AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
6.3.3 Canada AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
6.3.4 Mexico AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe AI-assisted Drug Design (AIDD) Consumption Value by Type (2018-2029)
7.2 Europe AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2029)
7.3 Europe AI-assisted Drug Design (AIDD) Market Size by Country
7.3.1 Europe AI-assisted Drug Design (AIDD) Consumption Value by Country (2018-2029)
7.3.2 Germany AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
7.3.3 France AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
7.3.4 United Kingdom AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
7.3.5 Russia AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
7.3.6 Italy AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value by Type (2018-2029)
8.2 Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2029)
8.3 Asia-Pacific AI-assisted Drug Design (AIDD) Market Size by Region
8.3.1 Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value by Region (2018-2029)
8.3.2 China AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
8.3.3 Japan AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
8.3.4 South Korea AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
8.3.5 India AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
8.3.7 Australia AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America AI-assisted Drug Design (AIDD) Consumption Value by Type (2018-2029)
9.2 South America AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2029)
9.3 South America AI-assisted Drug Design (AIDD) Market Size by Country
9.3.1 South America AI-assisted Drug Design (AIDD) Consumption Value by Country (2018-2029)
9.3.2 Brazil AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
9.3.3 Argentina AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AI-assisted Drug Design (AIDD) Consumption Value by Type (2018-2029)
10.2 Middle East & Africa AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2029)
10.3 Middle East & Africa AI-assisted Drug Design (AIDD) Market Size by Country
10.3.1 Middle East & Africa AI-assisted Drug Design (AIDD) Consumption Value by Country (2018-2029)
10.3.2 Turkey AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
10.3.4 UAE AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 AI-assisted Drug Design (AIDD) Market Drivers
11.2 AI-assisted Drug Design (AIDD) Market Restraints
11.3 AI-assisted Drug Design (AIDD) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 AI-assisted Drug Design (AIDD) Industry Chain
12.2 AI-assisted Drug Design (AIDD) Upstream Analysis
12.3 AI-assisted Drug Design (AIDD) Midstream Analysis
12.4 AI-assisted Drug Design (AIDD) Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of AI-assisted Drug Design (AIDD)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AI-assisted Drug Design (AIDD) by Type
1.3.1 Overview: Global AI-assisted Drug Design (AIDD) Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global AI-assisted Drug Design (AIDD) Consumption Value Market Share by Type in 2022
1.3.3 Hardware
1.3.4 Software
1.3.5 Service
1.4 Global AI-assisted Drug Design (AIDD) Market by Application
1.4.1 Overview: Global AI-assisted Drug Design (AIDD) Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Early Drug Discovery
1.4.3 Preclinical Phase
1.4.4 Clinical Phase
1.4.5 Regulatory Approval
1.5 Global AI-assisted Drug Design (AIDD) Market Size & Forecast
1.6 Global AI-assisted Drug Design (AIDD) Market Size and Forecast by Region
1.6.1 Global AI-assisted Drug Design (AIDD) Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global AI-assisted Drug Design (AIDD) Market Size by Region, (2018-2029)
1.6.3 North America AI-assisted Drug Design (AIDD) Market Size and Prospect (2018-2029)
1.6.4 Europe AI-assisted Drug Design (AIDD) Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific AI-assisted Drug Design (AIDD) Market Size and Prospect (2018-2029)
1.6.6 South America AI-assisted Drug Design (AIDD) Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa AI-assisted Drug Design (AIDD) Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 IBM
2.1.1 IBM Details
2.1.2 IBM Major Business
2.1.3 IBM AI-assisted Drug Design (AIDD) Product and Solutions
2.1.4 IBM AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 IBM Recent Developments and Future Plans
2.2 Exscientia
2.2.1 Exscientia Details
2.2.2 Exscientia Major Business
2.2.3 Exscientia AI-assisted Drug Design (AIDD) Product and Solutions
2.2.4 Exscientia AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Exscientia Recent Developments and Future Plans
2.3 Google(Alphabet)
2.3.1 Google(Alphabet) Details
2.3.2 Google(Alphabet) Major Business
2.3.3 Google(Alphabet) AI-assisted Drug Design (AIDD) Product and Solutions
2.3.4 Google(Alphabet) AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Google(Alphabet) Recent Developments and Future Plans
2.4 Microsoft
2.4.1 Microsoft Details
2.4.2 Microsoft Major Business
2.4.3 Microsoft AI-assisted Drug Design (AIDD) Product and Solutions
2.4.4 Microsoft AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Microsoft Recent Developments and Future Plans
2.5 Atomwise
2.5.1 Atomwise Details
2.5.2 Atomwise Major Business
2.5.3 Atomwise AI-assisted Drug Design (AIDD) Product and Solutions
2.5.4 Atomwise AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Atomwise Recent Developments and Future Plans
2.6 Schrodinger
2.6.1 Schrodinger Details
2.6.2 Schrodinger Major Business
2.6.3 Schrodinger AI-assisted Drug Design (AIDD) Product and Solutions
2.6.4 Schrodinger AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Schrodinger Recent Developments and Future Plans
2.7 Aitia
2.7.1 Aitia Details
2.7.2 Aitia Major Business
2.7.3 Aitia AI-assisted Drug Design (AIDD) Product and Solutions
2.7.4 Aitia AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Aitia Recent Developments and Future Plans
2.8 Insilico Medicine
2.8.1 Insilico Medicine Details
2.8.2 Insilico Medicine Major Business
2.8.3 Insilico Medicine AI-assisted Drug Design (AIDD) Product and Solutions
2.8.4 Insilico Medicine AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Insilico Medicine Recent Developments and Future Plans
2.9 NVIDIA
2.9.1 NVIDIA Details
2.9.2 NVIDIA Major Business
2.9.3 NVIDIA AI-assisted Drug Design (AIDD) Product and Solutions
2.9.4 NVIDIA AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 NVIDIA Recent Developments and Future Plans
2.10 XtalPi
2.10.1 XtalPi Details
2.10.2 XtalPi Major Business
2.10.3 XtalPi AI-assisted Drug Design (AIDD) Product and Solutions
2.10.4 XtalPi AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 XtalPi Recent Developments and Future Plans
2.11 BPGbio
2.11.1 BPGbio Details
2.11.2 BPGbio Major Business
2.11.3 BPGbio AI-assisted Drug Design (AIDD) Product and Solutions
2.11.4 BPGbio AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 BPGbio Recent Developments and Future Plans
2.12 Owkin
2.12.1 Owkin Details
2.12.2 Owkin Major Business
2.12.3 Owkin AI-assisted Drug Design (AIDD) Product and Solutions
2.12.4 Owkin AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Owkin Recent Developments and Future Plans
2.13 CytoReason
2.13.1 CytoReason Details
2.13.2 CytoReason Major Business
2.13.3 CytoReason AI-assisted Drug Design (AIDD) Product and Solutions
2.13.4 CytoReason AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 CytoReason Recent Developments and Future Plans
2.14 Deep Genomics
2.14.1 Deep Genomics Details
2.14.2 Deep Genomics Major Business
2.14.3 Deep Genomics AI-assisted Drug Design (AIDD) Product and Solutions
2.14.4 Deep Genomics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Deep Genomics Recent Developments and Future Plans
2.15 Cloud Pharmaceuticals
2.15.1 Cloud Pharmaceuticals Details
2.15.2 Cloud Pharmaceuticals Major Business
2.15.3 Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Product and Solutions
2.15.4 Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Cloud Pharmaceuticals Recent Developments and Future Plans
2.16 BenevolentAI
2.16.1 BenevolentAI Details
2.16.2 BenevolentAI Major Business
2.16.3 BenevolentAI AI-assisted Drug Design (AIDD) Product and Solutions
2.16.4 BenevolentAI AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 BenevolentAI Recent Developments and Future Plans
2.17 Cyclica
2.17.1 Cyclica Details
2.17.2 Cyclica Major Business
2.17.3 Cyclica AI-assisted Drug Design (AIDD) Product and Solutions
2.17.4 Cyclica AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Cyclica Recent Developments and Future Plans
2.18 Verge Genomics
2.18.1 Verge Genomics Details
2.18.2 Verge Genomics Major Business
2.18.3 Verge Genomics AI-assisted Drug Design (AIDD) Product and Solutions
2.18.4 Verge Genomics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Verge Genomics Recent Developments and Future Plans
2.19 Valo Health
2.19.1 Valo Health Details
2.19.2 Valo Health Major Business
2.19.3 Valo Health AI-assisted Drug Design (AIDD) Product and Solutions
2.19.4 Valo Health AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Valo Health Recent Developments and Future Plans
2.20 Envisagenics
2.20.1 Envisagenics Details
2.20.2 Envisagenics Major Business
2.20.3 Envisagenics AI-assisted Drug Design (AIDD) Product and Solutions
2.20.4 Envisagenics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Envisagenics Recent Developments and Future Plans
2.21 Euretos
2.21.1 Euretos Details
2.21.2 Euretos Major Business
2.21.3 Euretos AI-assisted Drug Design (AIDD) Product and Solutions
2.21.4 Euretos AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Euretos Recent Developments and Future Plans
2.22 BioAge Labs
2.22.1 BioAge Labs Details
2.22.2 BioAge Labs Major Business
2.22.3 BioAge Labs AI-assisted Drug Design (AIDD) Product and Solutions
2.22.4 BioAge Labs AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 BioAge Labs Recent Developments and Future Plans
2.23 Iktos
2.23.1 Iktos Details
2.23.2 Iktos Major Business
2.23.3 Iktos AI-assisted Drug Design (AIDD) Product and Solutions
2.23.4 Iktos AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Iktos Recent Developments and Future Plans
2.24 BioSymetrics
2.24.1 BioSymetrics Details
2.24.2 BioSymetrics Major Business
2.24.3 BioSymetrics AI-assisted Drug Design (AIDD) Product and Solutions
2.24.4 BioSymetrics AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 BioSymetrics Recent Developments and Future Plans
2.25 Evaxion Biotech
2.25.1 Evaxion Biotech Details
2.25.2 Evaxion Biotech Major Business
2.25.3 Evaxion Biotech AI-assisted Drug Design (AIDD) Product and Solutions
2.25.4 Evaxion Biotech AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.25.5 Evaxion Biotech Recent Developments and Future Plans
2.26 Aria Pharmaceuticals
2.26.1 Aria Pharmaceuticals Details
2.26.2 Aria Pharmaceuticals Major Business
2.26.3 Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Product and Solutions
2.26.4 Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue, Gross Margin and Market Share (2018-2023)
2.26.5 Aria Pharmaceuticals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AI-assisted Drug Design (AIDD) Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of AI-assisted Drug Design (AIDD) by Company Revenue
3.2.2 Top 3 AI-assisted Drug Design (AIDD) Players Market Share in 2022
3.2.3 Top 6 AI-assisted Drug Design (AIDD) Players Market Share in 2022
3.3 AI-assisted Drug Design (AIDD) Market: Overall Company Footprint Analysis
3.3.1 AI-assisted Drug Design (AIDD) Market: Region Footprint
3.3.2 AI-assisted Drug Design (AIDD) Market: Company Product Type Footprint
3.3.3 AI-assisted Drug Design (AIDD) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AI-assisted Drug Design (AIDD) Consumption Value and Market Share by Type (2018-2023)
4.2 Global AI-assisted Drug Design (AIDD) Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AI-assisted Drug Design (AIDD) Consumption Value Market Share by Application (2018-2023)
5.2 Global AI-assisted Drug Design (AIDD) Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America AI-assisted Drug Design (AIDD) Consumption Value by Type (2018-2029)
6.2 North America AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2029)
6.3 North America AI-assisted Drug Design (AIDD) Market Size by Country
6.3.1 North America AI-assisted Drug Design (AIDD) Consumption Value by Country (2018-2029)
6.3.2 United States AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
6.3.3 Canada AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
6.3.4 Mexico AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe AI-assisted Drug Design (AIDD) Consumption Value by Type (2018-2029)
7.2 Europe AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2029)
7.3 Europe AI-assisted Drug Design (AIDD) Market Size by Country
7.3.1 Europe AI-assisted Drug Design (AIDD) Consumption Value by Country (2018-2029)
7.3.2 Germany AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
7.3.3 France AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
7.3.4 United Kingdom AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
7.3.5 Russia AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
7.3.6 Italy AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value by Type (2018-2029)
8.2 Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2029)
8.3 Asia-Pacific AI-assisted Drug Design (AIDD) Market Size by Region
8.3.1 Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value by Region (2018-2029)
8.3.2 China AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
8.3.3 Japan AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
8.3.4 South Korea AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
8.3.5 India AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
8.3.7 Australia AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America AI-assisted Drug Design (AIDD) Consumption Value by Type (2018-2029)
9.2 South America AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2029)
9.3 South America AI-assisted Drug Design (AIDD) Market Size by Country
9.3.1 South America AI-assisted Drug Design (AIDD) Consumption Value by Country (2018-2029)
9.3.2 Brazil AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
9.3.3 Argentina AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AI-assisted Drug Design (AIDD) Consumption Value by Type (2018-2029)
10.2 Middle East & Africa AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2029)
10.3 Middle East & Africa AI-assisted Drug Design (AIDD) Market Size by Country
10.3.1 Middle East & Africa AI-assisted Drug Design (AIDD) Consumption Value by Country (2018-2029)
10.3.2 Turkey AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
10.3.4 UAE AI-assisted Drug Design (AIDD) Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 AI-assisted Drug Design (AIDD) Market Drivers
11.2 AI-assisted Drug Design (AIDD) Market Restraints
11.3 AI-assisted Drug Design (AIDD) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 AI-assisted Drug Design (AIDD) Industry Chain
12.2 AI-assisted Drug Design (AIDD) Upstream Analysis
12.3 AI-assisted Drug Design (AIDD) Midstream Analysis
12.4 AI-assisted Drug Design (AIDD) Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global AI-assisted Drug Design (AIDD) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global AI-assisted Drug Design (AIDD) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global AI-assisted Drug Design (AIDD) Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global AI-assisted Drug Design (AIDD) Consumption Value by Region (2024-2029) & (USD Million)
Table 5. IBM Company Information, Head Office, and Major Competitors
Table 6. IBM Major Business
Table 7. IBM AI-assisted Drug Design (AIDD) Product and Solutions
Table 8. IBM AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. IBM Recent Developments and Future Plans
Table 10. Exscientia Company Information, Head Office, and Major Competitors
Table 11. Exscientia Major Business
Table 12. Exscientia AI-assisted Drug Design (AIDD) Product and Solutions
Table 13. Exscientia AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Exscientia Recent Developments and Future Plans
Table 15. Google(Alphabet) Company Information, Head Office, and Major Competitors
Table 16. Google(Alphabet) Major Business
Table 17. Google(Alphabet) AI-assisted Drug Design (AIDD) Product and Solutions
Table 18. Google(Alphabet) AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Google(Alphabet) Recent Developments and Future Plans
Table 20. Microsoft Company Information, Head Office, and Major Competitors
Table 21. Microsoft Major Business
Table 22. Microsoft AI-assisted Drug Design (AIDD) Product and Solutions
Table 23. Microsoft AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Microsoft Recent Developments and Future Plans
Table 25. Atomwise Company Information, Head Office, and Major Competitors
Table 26. Atomwise Major Business
Table 27. Atomwise AI-assisted Drug Design (AIDD) Product and Solutions
Table 28. Atomwise AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Atomwise Recent Developments and Future Plans
Table 30. Schrodinger Company Information, Head Office, and Major Competitors
Table 31. Schrodinger Major Business
Table 32. Schrodinger AI-assisted Drug Design (AIDD) Product and Solutions
Table 33. Schrodinger AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Schrodinger Recent Developments and Future Plans
Table 35. Aitia Company Information, Head Office, and Major Competitors
Table 36. Aitia Major Business
Table 37. Aitia AI-assisted Drug Design (AIDD) Product and Solutions
Table 38. Aitia AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Aitia Recent Developments and Future Plans
Table 40. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 41. Insilico Medicine Major Business
Table 42. Insilico Medicine AI-assisted Drug Design (AIDD) Product and Solutions
Table 43. Insilico Medicine AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Insilico Medicine Recent Developments and Future Plans
Table 45. NVIDIA Company Information, Head Office, and Major Competitors
Table 46. NVIDIA Major Business
Table 47. NVIDIA AI-assisted Drug Design (AIDD) Product and Solutions
Table 48. NVIDIA AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. NVIDIA Recent Developments and Future Plans
Table 50. XtalPi Company Information, Head Office, and Major Competitors
Table 51. XtalPi Major Business
Table 52. XtalPi AI-assisted Drug Design (AIDD) Product and Solutions
Table 53. XtalPi AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. XtalPi Recent Developments and Future Plans
Table 55. BPGbio Company Information, Head Office, and Major Competitors
Table 56. BPGbio Major Business
Table 57. BPGbio AI-assisted Drug Design (AIDD) Product and Solutions
Table 58. BPGbio AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. BPGbio Recent Developments and Future Plans
Table 60. Owkin Company Information, Head Office, and Major Competitors
Table 61. Owkin Major Business
Table 62. Owkin AI-assisted Drug Design (AIDD) Product and Solutions
Table 63. Owkin AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Owkin Recent Developments and Future Plans
Table 65. CytoReason Company Information, Head Office, and Major Competitors
Table 66. CytoReason Major Business
Table 67. CytoReason AI-assisted Drug Design (AIDD) Product and Solutions
Table 68. CytoReason AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. CytoReason Recent Developments and Future Plans
Table 70. Deep Genomics Company Information, Head Office, and Major Competitors
Table 71. Deep Genomics Major Business
Table 72. Deep Genomics AI-assisted Drug Design (AIDD) Product and Solutions
Table 73. Deep Genomics AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Deep Genomics Recent Developments and Future Plans
Table 75. Cloud Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 76. Cloud Pharmaceuticals Major Business
Table 77. Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Product and Solutions
Table 78. Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Cloud Pharmaceuticals Recent Developments and Future Plans
Table 80. BenevolentAI Company Information, Head Office, and Major Competitors
Table 81. BenevolentAI Major Business
Table 82. BenevolentAI AI-assisted Drug Design (AIDD) Product and Solutions
Table 83. BenevolentAI AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. BenevolentAI Recent Developments and Future Plans
Table 85. Cyclica Company Information, Head Office, and Major Competitors
Table 86. Cyclica Major Business
Table 87. Cyclica AI-assisted Drug Design (AIDD) Product and Solutions
Table 88. Cyclica AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Cyclica Recent Developments and Future Plans
Table 90. Verge Genomics Company Information, Head Office, and Major Competitors
Table 91. Verge Genomics Major Business
Table 92. Verge Genomics AI-assisted Drug Design (AIDD) Product and Solutions
Table 93. Verge Genomics AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Verge Genomics Recent Developments and Future Plans
Table 95. Valo Health Company Information, Head Office, and Major Competitors
Table 96. Valo Health Major Business
Table 97. Valo Health AI-assisted Drug Design (AIDD) Product and Solutions
Table 98. Valo Health AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Valo Health Recent Developments and Future Plans
Table 100. Envisagenics Company Information, Head Office, and Major Competitors
Table 101. Envisagenics Major Business
Table 102. Envisagenics AI-assisted Drug Design (AIDD) Product and Solutions
Table 103. Envisagenics AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Envisagenics Recent Developments and Future Plans
Table 105. Euretos Company Information, Head Office, and Major Competitors
Table 106. Euretos Major Business
Table 107. Euretos AI-assisted Drug Design (AIDD) Product and Solutions
Table 108. Euretos AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Euretos Recent Developments and Future Plans
Table 110. BioAge Labs Company Information, Head Office, and Major Competitors
Table 111. BioAge Labs Major Business
Table 112. BioAge Labs AI-assisted Drug Design (AIDD) Product and Solutions
Table 113. BioAge Labs AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. BioAge Labs Recent Developments and Future Plans
Table 115. Iktos Company Information, Head Office, and Major Competitors
Table 116. Iktos Major Business
Table 117. Iktos AI-assisted Drug Design (AIDD) Product and Solutions
Table 118. Iktos AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Iktos Recent Developments and Future Plans
Table 120. BioSymetrics Company Information, Head Office, and Major Competitors
Table 121. BioSymetrics Major Business
Table 122. BioSymetrics AI-assisted Drug Design (AIDD) Product and Solutions
Table 123. BioSymetrics AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. BioSymetrics Recent Developments and Future Plans
Table 125. Evaxion Biotech Company Information, Head Office, and Major Competitors
Table 126. Evaxion Biotech Major Business
Table 127. Evaxion Biotech AI-assisted Drug Design (AIDD) Product and Solutions
Table 128. Evaxion Biotech AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 129. Evaxion Biotech Recent Developments and Future Plans
Table 130. Aria Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 131. Aria Pharmaceuticals Major Business
Table 132. Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Product and Solutions
Table 133. Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 134. Aria Pharmaceuticals Recent Developments and Future Plans
Table 135. Global AI-assisted Drug Design (AIDD) Revenue (USD Million) by Players (2018-2023)
Table 136. Global AI-assisted Drug Design (AIDD) Revenue Share by Players (2018-2023)
Table 137. Breakdown of AI-assisted Drug Design (AIDD) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 138. Market Position of Players in AI-assisted Drug Design (AIDD), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 139. Head Office of Key AI-assisted Drug Design (AIDD) Players
Table 140. AI-assisted Drug Design (AIDD) Market: Company Product Type Footprint
Table 141. AI-assisted Drug Design (AIDD) Market: Company Product Application Footprint
Table 142. AI-assisted Drug Design (AIDD) New Market Entrants and Barriers to Market Entry
Table 143. AI-assisted Drug Design (AIDD) Mergers, Acquisition, Agreements, and Collaborations
Table 144. Global AI-assisted Drug Design (AIDD) Consumption Value (USD Million) by Type (2018-2023)
Table 145. Global AI-assisted Drug Design (AIDD) Consumption Value Share by Type (2018-2023)
Table 146. Global AI-assisted Drug Design (AIDD) Consumption Value Forecast by Type (2024-2029)
Table 147. Global AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2023)
Table 148. Global AI-assisted Drug Design (AIDD) Consumption Value Forecast by Application (2024-2029)
Table 149. North America AI-assisted Drug Design (AIDD) Consumption Value by Type (2018-2023) & (USD Million)
Table 150. North America AI-assisted Drug Design (AIDD) Consumption Value by Type (2024-2029) & (USD Million)
Table 151. North America AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2023) & (USD Million)
Table 152. North America AI-assisted Drug Design (AIDD) Consumption Value by Application (2024-2029) & (USD Million)
Table 153. North America AI-assisted Drug Design (AIDD) Consumption Value by Country (2018-2023) & (USD Million)
Table 154. North America AI-assisted Drug Design (AIDD) Consumption Value by Country (2024-2029) & (USD Million)
Table 155. Europe AI-assisted Drug Design (AIDD) Consumption Value by Type (2018-2023) & (USD Million)
Table 156. Europe AI-assisted Drug Design (AIDD) Consumption Value by Type (2024-2029) & (USD Million)
Table 157. Europe AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2023) & (USD Million)
Table 158. Europe AI-assisted Drug Design (AIDD) Consumption Value by Application (2024-2029) & (USD Million)
Table 159. Europe AI-assisted Drug Design (AIDD) Consumption Value by Country (2018-2023) & (USD Million)
Table 160. Europe AI-assisted Drug Design (AIDD) Consumption Value by Country (2024-2029) & (USD Million)
Table 161. Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value by Type (2018-2023) & (USD Million)
Table 162. Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value by Type (2024-2029) & (USD Million)
Table 163. Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2023) & (USD Million)
Table 164. Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value by Application (2024-2029) & (USD Million)
Table 165. Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value by Region (2018-2023) & (USD Million)
Table 166. Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value by Region (2024-2029) & (USD Million)
Table 167. South America AI-assisted Drug Design (AIDD) Consumption Value by Type (2018-2023) & (USD Million)
Table 168. South America AI-assisted Drug Design (AIDD) Consumption Value by Type (2024-2029) & (USD Million)
Table 169. South America AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2023) & (USD Million)
Table 170. South America AI-assisted Drug Design (AIDD) Consumption Value by Application (2024-2029) & (USD Million)
Table 171. South America AI-assisted Drug Design (AIDD) Consumption Value by Country (2018-2023) & (USD Million)
Table 172. South America AI-assisted Drug Design (AIDD) Consumption Value by Country (2024-2029) & (USD Million)
Table 173. Middle East & Africa AI-assisted Drug Design (AIDD) Consumption Value by Type (2018-2023) & (USD Million)
Table 174. Middle East & Africa AI-assisted Drug Design (AIDD) Consumption Value by Type (2024-2029) & (USD Million)
Table 175. Middle East & Africa AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2023) & (USD Million)
Table 176. Middle East & Africa AI-assisted Drug Design (AIDD) Consumption Value by Application (2024-2029) & (USD Million)
Table 177. Middle East & Africa AI-assisted Drug Design (AIDD) Consumption Value by Country (2018-2023) & (USD Million)
Table 178. Middle East & Africa AI-assisted Drug Design (AIDD) Consumption Value by Country (2024-2029) & (USD Million)
Table 179. AI-assisted Drug Design (AIDD) Raw Material
Table 180. Key Suppliers of AI-assisted Drug Design (AIDD) Raw Materials
Table 1. Global AI-assisted Drug Design (AIDD) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global AI-assisted Drug Design (AIDD) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global AI-assisted Drug Design (AIDD) Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global AI-assisted Drug Design (AIDD) Consumption Value by Region (2024-2029) & (USD Million)
Table 5. IBM Company Information, Head Office, and Major Competitors
Table 6. IBM Major Business
Table 7. IBM AI-assisted Drug Design (AIDD) Product and Solutions
Table 8. IBM AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. IBM Recent Developments and Future Plans
Table 10. Exscientia Company Information, Head Office, and Major Competitors
Table 11. Exscientia Major Business
Table 12. Exscientia AI-assisted Drug Design (AIDD) Product and Solutions
Table 13. Exscientia AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Exscientia Recent Developments and Future Plans
Table 15. Google(Alphabet) Company Information, Head Office, and Major Competitors
Table 16. Google(Alphabet) Major Business
Table 17. Google(Alphabet) AI-assisted Drug Design (AIDD) Product and Solutions
Table 18. Google(Alphabet) AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Google(Alphabet) Recent Developments and Future Plans
Table 20. Microsoft Company Information, Head Office, and Major Competitors
Table 21. Microsoft Major Business
Table 22. Microsoft AI-assisted Drug Design (AIDD) Product and Solutions
Table 23. Microsoft AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Microsoft Recent Developments and Future Plans
Table 25. Atomwise Company Information, Head Office, and Major Competitors
Table 26. Atomwise Major Business
Table 27. Atomwise AI-assisted Drug Design (AIDD) Product and Solutions
Table 28. Atomwise AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Atomwise Recent Developments and Future Plans
Table 30. Schrodinger Company Information, Head Office, and Major Competitors
Table 31. Schrodinger Major Business
Table 32. Schrodinger AI-assisted Drug Design (AIDD) Product and Solutions
Table 33. Schrodinger AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Schrodinger Recent Developments and Future Plans
Table 35. Aitia Company Information, Head Office, and Major Competitors
Table 36. Aitia Major Business
Table 37. Aitia AI-assisted Drug Design (AIDD) Product and Solutions
Table 38. Aitia AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Aitia Recent Developments and Future Plans
Table 40. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 41. Insilico Medicine Major Business
Table 42. Insilico Medicine AI-assisted Drug Design (AIDD) Product and Solutions
Table 43. Insilico Medicine AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Insilico Medicine Recent Developments and Future Plans
Table 45. NVIDIA Company Information, Head Office, and Major Competitors
Table 46. NVIDIA Major Business
Table 47. NVIDIA AI-assisted Drug Design (AIDD) Product and Solutions
Table 48. NVIDIA AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. NVIDIA Recent Developments and Future Plans
Table 50. XtalPi Company Information, Head Office, and Major Competitors
Table 51. XtalPi Major Business
Table 52. XtalPi AI-assisted Drug Design (AIDD) Product and Solutions
Table 53. XtalPi AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. XtalPi Recent Developments and Future Plans
Table 55. BPGbio Company Information, Head Office, and Major Competitors
Table 56. BPGbio Major Business
Table 57. BPGbio AI-assisted Drug Design (AIDD) Product and Solutions
Table 58. BPGbio AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. BPGbio Recent Developments and Future Plans
Table 60. Owkin Company Information, Head Office, and Major Competitors
Table 61. Owkin Major Business
Table 62. Owkin AI-assisted Drug Design (AIDD) Product and Solutions
Table 63. Owkin AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Owkin Recent Developments and Future Plans
Table 65. CytoReason Company Information, Head Office, and Major Competitors
Table 66. CytoReason Major Business
Table 67. CytoReason AI-assisted Drug Design (AIDD) Product and Solutions
Table 68. CytoReason AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. CytoReason Recent Developments and Future Plans
Table 70. Deep Genomics Company Information, Head Office, and Major Competitors
Table 71. Deep Genomics Major Business
Table 72. Deep Genomics AI-assisted Drug Design (AIDD) Product and Solutions
Table 73. Deep Genomics AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Deep Genomics Recent Developments and Future Plans
Table 75. Cloud Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 76. Cloud Pharmaceuticals Major Business
Table 77. Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Product and Solutions
Table 78. Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Cloud Pharmaceuticals Recent Developments and Future Plans
Table 80. BenevolentAI Company Information, Head Office, and Major Competitors
Table 81. BenevolentAI Major Business
Table 82. BenevolentAI AI-assisted Drug Design (AIDD) Product and Solutions
Table 83. BenevolentAI AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. BenevolentAI Recent Developments and Future Plans
Table 85. Cyclica Company Information, Head Office, and Major Competitors
Table 86. Cyclica Major Business
Table 87. Cyclica AI-assisted Drug Design (AIDD) Product and Solutions
Table 88. Cyclica AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Cyclica Recent Developments and Future Plans
Table 90. Verge Genomics Company Information, Head Office, and Major Competitors
Table 91. Verge Genomics Major Business
Table 92. Verge Genomics AI-assisted Drug Design (AIDD) Product and Solutions
Table 93. Verge Genomics AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Verge Genomics Recent Developments and Future Plans
Table 95. Valo Health Company Information, Head Office, and Major Competitors
Table 96. Valo Health Major Business
Table 97. Valo Health AI-assisted Drug Design (AIDD) Product and Solutions
Table 98. Valo Health AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Valo Health Recent Developments and Future Plans
Table 100. Envisagenics Company Information, Head Office, and Major Competitors
Table 101. Envisagenics Major Business
Table 102. Envisagenics AI-assisted Drug Design (AIDD) Product and Solutions
Table 103. Envisagenics AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Envisagenics Recent Developments and Future Plans
Table 105. Euretos Company Information, Head Office, and Major Competitors
Table 106. Euretos Major Business
Table 107. Euretos AI-assisted Drug Design (AIDD) Product and Solutions
Table 108. Euretos AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Euretos Recent Developments and Future Plans
Table 110. BioAge Labs Company Information, Head Office, and Major Competitors
Table 111. BioAge Labs Major Business
Table 112. BioAge Labs AI-assisted Drug Design (AIDD) Product and Solutions
Table 113. BioAge Labs AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. BioAge Labs Recent Developments and Future Plans
Table 115. Iktos Company Information, Head Office, and Major Competitors
Table 116. Iktos Major Business
Table 117. Iktos AI-assisted Drug Design (AIDD) Product and Solutions
Table 118. Iktos AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Iktos Recent Developments and Future Plans
Table 120. BioSymetrics Company Information, Head Office, and Major Competitors
Table 121. BioSymetrics Major Business
Table 122. BioSymetrics AI-assisted Drug Design (AIDD) Product and Solutions
Table 123. BioSymetrics AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. BioSymetrics Recent Developments and Future Plans
Table 125. Evaxion Biotech Company Information, Head Office, and Major Competitors
Table 126. Evaxion Biotech Major Business
Table 127. Evaxion Biotech AI-assisted Drug Design (AIDD) Product and Solutions
Table 128. Evaxion Biotech AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 129. Evaxion Biotech Recent Developments and Future Plans
Table 130. Aria Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 131. Aria Pharmaceuticals Major Business
Table 132. Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Product and Solutions
Table 133. Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 134. Aria Pharmaceuticals Recent Developments and Future Plans
Table 135. Global AI-assisted Drug Design (AIDD) Revenue (USD Million) by Players (2018-2023)
Table 136. Global AI-assisted Drug Design (AIDD) Revenue Share by Players (2018-2023)
Table 137. Breakdown of AI-assisted Drug Design (AIDD) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 138. Market Position of Players in AI-assisted Drug Design (AIDD), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 139. Head Office of Key AI-assisted Drug Design (AIDD) Players
Table 140. AI-assisted Drug Design (AIDD) Market: Company Product Type Footprint
Table 141. AI-assisted Drug Design (AIDD) Market: Company Product Application Footprint
Table 142. AI-assisted Drug Design (AIDD) New Market Entrants and Barriers to Market Entry
Table 143. AI-assisted Drug Design (AIDD) Mergers, Acquisition, Agreements, and Collaborations
Table 144. Global AI-assisted Drug Design (AIDD) Consumption Value (USD Million) by Type (2018-2023)
Table 145. Global AI-assisted Drug Design (AIDD) Consumption Value Share by Type (2018-2023)
Table 146. Global AI-assisted Drug Design (AIDD) Consumption Value Forecast by Type (2024-2029)
Table 147. Global AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2023)
Table 148. Global AI-assisted Drug Design (AIDD) Consumption Value Forecast by Application (2024-2029)
Table 149. North America AI-assisted Drug Design (AIDD) Consumption Value by Type (2018-2023) & (USD Million)
Table 150. North America AI-assisted Drug Design (AIDD) Consumption Value by Type (2024-2029) & (USD Million)
Table 151. North America AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2023) & (USD Million)
Table 152. North America AI-assisted Drug Design (AIDD) Consumption Value by Application (2024-2029) & (USD Million)
Table 153. North America AI-assisted Drug Design (AIDD) Consumption Value by Country (2018-2023) & (USD Million)
Table 154. North America AI-assisted Drug Design (AIDD) Consumption Value by Country (2024-2029) & (USD Million)
Table 155. Europe AI-assisted Drug Design (AIDD) Consumption Value by Type (2018-2023) & (USD Million)
Table 156. Europe AI-assisted Drug Design (AIDD) Consumption Value by Type (2024-2029) & (USD Million)
Table 157. Europe AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2023) & (USD Million)
Table 158. Europe AI-assisted Drug Design (AIDD) Consumption Value by Application (2024-2029) & (USD Million)
Table 159. Europe AI-assisted Drug Design (AIDD) Consumption Value by Country (2018-2023) & (USD Million)
Table 160. Europe AI-assisted Drug Design (AIDD) Consumption Value by Country (2024-2029) & (USD Million)
Table 161. Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value by Type (2018-2023) & (USD Million)
Table 162. Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value by Type (2024-2029) & (USD Million)
Table 163. Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2023) & (USD Million)
Table 164. Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value by Application (2024-2029) & (USD Million)
Table 165. Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value by Region (2018-2023) & (USD Million)
Table 166. Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value by Region (2024-2029) & (USD Million)
Table 167. South America AI-assisted Drug Design (AIDD) Consumption Value by Type (2018-2023) & (USD Million)
Table 168. South America AI-assisted Drug Design (AIDD) Consumption Value by Type (2024-2029) & (USD Million)
Table 169. South America AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2023) & (USD Million)
Table 170. South America AI-assisted Drug Design (AIDD) Consumption Value by Application (2024-2029) & (USD Million)
Table 171. South America AI-assisted Drug Design (AIDD) Consumption Value by Country (2018-2023) & (USD Million)
Table 172. South America AI-assisted Drug Design (AIDD) Consumption Value by Country (2024-2029) & (USD Million)
Table 173. Middle East & Africa AI-assisted Drug Design (AIDD) Consumption Value by Type (2018-2023) & (USD Million)
Table 174. Middle East & Africa AI-assisted Drug Design (AIDD) Consumption Value by Type (2024-2029) & (USD Million)
Table 175. Middle East & Africa AI-assisted Drug Design (AIDD) Consumption Value by Application (2018-2023) & (USD Million)
Table 176. Middle East & Africa AI-assisted Drug Design (AIDD) Consumption Value by Application (2024-2029) & (USD Million)
Table 177. Middle East & Africa AI-assisted Drug Design (AIDD) Consumption Value by Country (2018-2023) & (USD Million)
Table 178. Middle East & Africa AI-assisted Drug Design (AIDD) Consumption Value by Country (2024-2029) & (USD Million)
Table 179. AI-assisted Drug Design (AIDD) Raw Material
Table 180. Key Suppliers of AI-assisted Drug Design (AIDD) Raw Materials
LIST OF FIGURES
Figure 1. AI-assisted Drug Design (AIDD) Picture
Figure 2. Global AI-assisted Drug Design (AIDD) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global AI-assisted Drug Design (AIDD) Consumption Value Market Share by Type in 2022
Figure 4. Hardware
Figure 5. Software
Figure 6. Service
Figure 7. Global AI-assisted Drug Design (AIDD) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. AI-assisted Drug Design (AIDD) Consumption Value Market Share by Application in 2022
Figure 9. Early Drug Discovery Picture
Figure 10. Preclinical Phase Picture
Figure 11. Clinical Phase Picture
Figure 12. Regulatory Approval Picture
Figure 13. Global AI-assisted Drug Design (AIDD) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global AI-assisted Drug Design (AIDD) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market AI-assisted Drug Design (AIDD) Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global AI-assisted Drug Design (AIDD) Consumption Value Market Share by Region (2018-2029)
Figure 17. Global AI-assisted Drug Design (AIDD) Consumption Value Market Share by Region in 2022
Figure 18. North America AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 21. South America AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 23. Global AI-assisted Drug Design (AIDD) Revenue Share by Players in 2022
Figure 24. AI-assisted Drug Design (AIDD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players AI-assisted Drug Design (AIDD) Market Share in 2022
Figure 26. Global Top 6 Players AI-assisted Drug Design (AIDD) Market Share in 2022
Figure 27. Global AI-assisted Drug Design (AIDD) Consumption Value Share by Type (2018-2023)
Figure 28. Global AI-assisted Drug Design (AIDD) Market Share Forecast by Type (2024-2029)
Figure 29. Global AI-assisted Drug Design (AIDD) Consumption Value Share by Application (2018-2023)
Figure 30. Global AI-assisted Drug Design (AIDD) Market Share Forecast by Application (2024-2029)
Figure 31. North America AI-assisted Drug Design (AIDD) Consumption Value Market Share by Type (2018-2029)
Figure 32. North America AI-assisted Drug Design (AIDD) Consumption Value Market Share by Application (2018-2029)
Figure 33. North America AI-assisted Drug Design (AIDD) Consumption Value Market Share by Country (2018-2029)
Figure 34. United States AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe AI-assisted Drug Design (AIDD) Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe AI-assisted Drug Design (AIDD) Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe AI-assisted Drug Design (AIDD) Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 41. France AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value Market Share by Region (2018-2029)
Figure 48. China AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 51. India AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 54. South America AI-assisted Drug Design (AIDD) Consumption Value Market Share by Type (2018-2029)
Figure 55. South America AI-assisted Drug Design (AIDD) Consumption Value Market Share by Application (2018-2029)
Figure 56. South America AI-assisted Drug Design (AIDD) Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa AI-assisted Drug Design (AIDD) Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa AI-assisted Drug Design (AIDD) Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa AI-assisted Drug Design (AIDD) Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 65. AI-assisted Drug Design (AIDD) Market Drivers
Figure 66. AI-assisted Drug Design (AIDD) Market Restraints
Figure 67. AI-assisted Drug Design (AIDD) Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of AI-assisted Drug Design (AIDD) in 2022
Figure 70. Manufacturing Process Analysis of AI-assisted Drug Design (AIDD)
Figure 71. AI-assisted Drug Design (AIDD) Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. AI-assisted Drug Design (AIDD) Picture
Figure 2. Global AI-assisted Drug Design (AIDD) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global AI-assisted Drug Design (AIDD) Consumption Value Market Share by Type in 2022
Figure 4. Hardware
Figure 5. Software
Figure 6. Service
Figure 7. Global AI-assisted Drug Design (AIDD) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. AI-assisted Drug Design (AIDD) Consumption Value Market Share by Application in 2022
Figure 9. Early Drug Discovery Picture
Figure 10. Preclinical Phase Picture
Figure 11. Clinical Phase Picture
Figure 12. Regulatory Approval Picture
Figure 13. Global AI-assisted Drug Design (AIDD) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global AI-assisted Drug Design (AIDD) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market AI-assisted Drug Design (AIDD) Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global AI-assisted Drug Design (AIDD) Consumption Value Market Share by Region (2018-2029)
Figure 17. Global AI-assisted Drug Design (AIDD) Consumption Value Market Share by Region in 2022
Figure 18. North America AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 21. South America AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 23. Global AI-assisted Drug Design (AIDD) Revenue Share by Players in 2022
Figure 24. AI-assisted Drug Design (AIDD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players AI-assisted Drug Design (AIDD) Market Share in 2022
Figure 26. Global Top 6 Players AI-assisted Drug Design (AIDD) Market Share in 2022
Figure 27. Global AI-assisted Drug Design (AIDD) Consumption Value Share by Type (2018-2023)
Figure 28. Global AI-assisted Drug Design (AIDD) Market Share Forecast by Type (2024-2029)
Figure 29. Global AI-assisted Drug Design (AIDD) Consumption Value Share by Application (2018-2023)
Figure 30. Global AI-assisted Drug Design (AIDD) Market Share Forecast by Application (2024-2029)
Figure 31. North America AI-assisted Drug Design (AIDD) Consumption Value Market Share by Type (2018-2029)
Figure 32. North America AI-assisted Drug Design (AIDD) Consumption Value Market Share by Application (2018-2029)
Figure 33. North America AI-assisted Drug Design (AIDD) Consumption Value Market Share by Country (2018-2029)
Figure 34. United States AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe AI-assisted Drug Design (AIDD) Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe AI-assisted Drug Design (AIDD) Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe AI-assisted Drug Design (AIDD) Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 41. France AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific AI-assisted Drug Design (AIDD) Consumption Value Market Share by Region (2018-2029)
Figure 48. China AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 51. India AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 54. South America AI-assisted Drug Design (AIDD) Consumption Value Market Share by Type (2018-2029)
Figure 55. South America AI-assisted Drug Design (AIDD) Consumption Value Market Share by Application (2018-2029)
Figure 56. South America AI-assisted Drug Design (AIDD) Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa AI-assisted Drug Design (AIDD) Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa AI-assisted Drug Design (AIDD) Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa AI-assisted Drug Design (AIDD) Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE AI-assisted Drug Design (AIDD) Consumption Value (2018-2029) & (USD Million)
Figure 65. AI-assisted Drug Design (AIDD) Market Drivers
Figure 66. AI-assisted Drug Design (AIDD) Market Restraints
Figure 67. AI-assisted Drug Design (AIDD) Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of AI-assisted Drug Design (AIDD) in 2022
Figure 70. Manufacturing Process Analysis of AI-assisted Drug Design (AIDD)
Figure 71. AI-assisted Drug Design (AIDD) Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
